US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

62.00

-0.6200-0.99%

Volume:166.95K

Turnover:10.33M

Market Cap:9.23B

PE:-8.10

High:63.05

Open:62.30

Low:61.23

Close:62.62

52wk High:65.00

52wk Low:29.87

Shares:148.81M

Float Shares:136.00M

Volume Ratio:0.51

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.6496

EPS(LYR):-5.6333

ROE:-36.51%

ROA:-22.61%

PB:3.35

PE(LYR):-11.01

Loading ...

Overview Company News Filings

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and Vaxcyte (PCVX)

Vaxcyte SVP Finance Elvia Cowan disposes of USD 180,000 common shares

Vaxcyte to present at Needham Virtual Healthcare Conference fireside chat

Vaxcyte (PCVX) Valuation Check As VAX-31 Phase 3 OPUS Trials Reach Full Enrollment

Simply Wall St.

Vaxcyte COO Jim Wassil disposes of common shares worth $0.1 million

Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer

Vaxcyte completes enrollment in OPUS-1 and OPUS-2 Phase 3 trials of VAX-31 in about 5,300 adults

Vaxcyte Inc - Opus-3 Phase 3 Results Expected in First Half of 2027

THOMSON REUTERS

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

Will VAX-31’s Phase 3 OPUS Progress and Broader Serotype Coverage Change Vaxcyte’s (PCVX) Narrative

Simply Wall St.

Assessing Vaxcyte (PCVX) Valuation After Strong VAX 31 Phase 1/2 Results In The Lancet

Simply Wall St.

Vaxcyte reports positive VAX-31 phase 1/2 adult data published in The Lancet

Vaxcyte Inc - Publishes Positive Vax-31 Phase 1/2 Adult Study Results in the Lancet Infectious Diseases

THOMSON REUTERS

Vaxcyte Inc - Study Results Showed That Vax-31 Was Observed to Be Well Tolerated

THOMSON REUTERS

Vaxcyte reports Phase 1/2 adult data showing VAX-31 met noninferiority to Prevnar 20 and achieved ~95% IPD coverage

Vaxcyte SVP Finance and CAO Elvia Cowan disposes of USD 104,979 of common shares

Vaxcyte COO Jim Wassil Disposes of Common Shares

Vaxcyte Earnings Call: Cash Strength, Trials Accelerate

Vaxcyte (PCVX) Is Up 5.5% After Unveiling VAX-31 Data, Phase 3 Plans And New Financing - Has The Bull Case Changed?

Simply Wall St.

Stock Track | Vaxcyte, Inc. Plummets 5.05% Intraday on FDA Regulatory Timing Risk Disclosure

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PCVX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PCVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","market":"US","secType":"STK","nameCN":"Vaxcyte, Inc.","latestPrice":62,"timestamp":1787586337498,"preClose":62.62,"halted":0,"volume":166948,"delay":0,"changeRate":-0.009900990099009861,"floatShares":136000000,"shares":148805278,"eps":-7.649608,"marketStatus":"Trading","change":-0.62,"latestTime":"08-24 11:45:45 EDT","open":62.3,"high":63.05,"low":61.23,"amount":10325803.584263999,"amplitude":0.029064,"askPrice":62.08,"askSize":43,"bidPrice":61.96,"bidSize":22,"shortable":3,"etf":0,"ttmEps":-7.649608,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":62.62,"preHourTrading":{"tag":"盘前","latestPrice":62.581,"preClose":62.62,"latestTime":"09:03 EDT","volume":1555,"amount":97210.1719,"timestamp":1787576615018,"change":-0.039,"changeRate":-0.000623,"amplitude":0.011817},"postHourTrading":{"tag":"盘后","latestPrice":62.85,"preClose":62.62,"latestTime":"19:30 EDT","volume":14502,"amount":908405.7,"timestamp":1787355006268,"change":0.23,"changeRate":0.003673,"amplitude":0.019483},"volumeRatio":0.505893,"impliedVol":0.491,"impliedVolPercentile":0.3028},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","floatShares":136000000,"roa":"-22.61%","roe":"-36.51%","lyrEps":-5.633263,"volumeRatio":0.505893,"shares":148805278,"dividePrice":0,"high":63.05,"amplitude":0.029064,"preClose":62.62,"low":61.23,"week52Low":29.87,"pbRate":"3.35","week52High":65,"institutionHeld":0,"latestPrice":62,"committee":-0.323077,"eps":-7.649608,"divideRate":0,"volume":166948,"delay":0,"ttmEps":-7.649608,"open":62.3,"prevYearClose":46.14,"prevWeekClose":62.62,"prevMonthClose":54.08,"prevQuarterClose":58.13,"fiveDayClose":60.22,"twentyDayClose":55.5,"sixtyDayClose":51.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"PCVX","fiscalQuarterEnding":"2026/06","expectedEps":-1.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-1.97},{"market":"US","date":"2026-05-06","symbol":"PCVX","fiscalQuarterEnding":"2026/03","expectedEps":-1.86,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-2.3},{"market":"US","date":"2026-02-24","symbol":"PCVX","fiscalQuarterEnding":"2025/12","expectedEps":-1.46,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":-1.8},{"market":"US","date":"2025-11-04","symbol":"PCVX","fiscalQuarterEnding":"2025/09","expectedEps":-1.27,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-1.56},{"market":"US","date":"2025-08-06","symbol":"PCVX","fiscalQuarterEnding":"2025/06","expectedEps":-1.12,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-1.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4545,"buy":0.4545,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4545,"analysts":11,"updateTime":1769832000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PCVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PCVX","date":"2026-08-21","current":-8.073616,"percent":0.882691,"low":-29.340195,"twenty":-19.835244,"median":-14.441039,"eighty":-9.528943,"high":-6.929024,"avg":-15.004802,"sd":5.405537,"marketCap":9127715752},"quantilePoints":[{"date":"2021-08-27","current":-16.044529,"twenty":-31.042745,"median":-16.118553,"eighty":-13.486858,"marketCap":1390322658},{"date":"2021-09-03","current":-15.454303,"twenty":-30.799298,"median":-16.056575,"eighty":-13.501305,"marketCap":1339177155},{"date":"2021-09-10","current":-15.755439,"twenty":-30.533651,"median":-16.044529,"eighty":-13.509778,"marketCap":1365271800},{"date":"2021-09-17","current":-15.273621,"twenty":-30.399459,"median":-16.002108,"eighty":-13.545554,"marketCap":1323520369},{"date":"2021-09-24","current":-15.526575,"twenty":-30.296,"median":-15.971408,"eighty":-13.571461,"marketCap":1345439870},{"date":"2021-10-01","current":-15.797598,"twenty":-30.252261,"median":-15.938491,"eighty":-13.585031,"marketCap":1368925050},{"date":"2021-10-08","current":-14.544872,"twenty":-30.181073,"median":-15.881916,"eighty":-13.619573,"marketCap":1260371329},{"date":"2021-10-15","current":-14.701463,"twenty":-30.038168,"median":-15.83959,"eighty":-13.634377,"marketCap":1273940544},{"date":"2021-10-22","current":-13.6776,"twenty":-29.986874,"median":-15.836525,"eighty":-13.619573,"marketCap":1185218753},{"date":"2021-10-29","current":-14.093168,"twenty":-29.919091,"median":-15.822921,"eighty":-13.619573,"marketCap":1221229362},{"date":"2021-11-05","current":-15.243508,"twenty":-29.833872,"median":-15.797598,"eighty":-13.623951,"marketCap":1320910904},{"date":"2021-11-12","current":-15.134436,"twenty":-29.751073,"median":-15.774414,"eighty":-13.643873,"marketCap":1396166847},{"date":"2021-11-19","current":-12.994444,"twenty":-29.640151,"median":-15.762952,"eighty":-13.643873,"marketCap":1198750438},{"date":"2021-11-26","current":-11.363701,"twenty":-29.615934,"median":-15.755439,"eighty":-13.576395,"marketCap":1048312800},{"date":"2021-12-03","current":-11.054718,"twenty":-29.492837,"median":-15.662087,"eighty":-13.502376,"marketCap":1019808827},{"date":"2021-12-10","current":-12.439419,"twenty":-29.474665,"median":-15.610894,"eighty":-13.409852,"marketCap":1147548856},{"date":"2021-12-17","current":-12.679739,"twenty":-29.293034,"median":-15.552798,"eighty":-13.261813,"marketCap":1169718613},{"date":"2021-12-23","current":-13.82412,"twenty":-29.268816,"median":-15.502485,"eighty":-13.260579,"marketCap":1275288885},{"date":"2021-12-31","current":-13.612409,"twenty":-29.21926,"median":-15.450268,"eighty":-13.25441,"marketCap":1255758385},{"date":"2022-01-07","current":-13.612409,"twenty":-29.141782,"median":-15.412813,"eighty":-13.260579,"marketCap":1255758385},{"date":"2022-01-14","current":-11.644212,"twenty":-29.049569,"median":-15.345894,"eighty":-13.248242,"marketCap":1074190192},{"date":"2022-01-21","current":-10.46361,"twenty":-28.988298,"median":-15.279644,"eighty":-13.177704,"marketCap":965278474},{"date":"2022-01-28","current":-10.685347,"twenty":-28.867611,"median":-15.231462,"eighty":-13.055331,"marketCap":985733974},{"date":"2022-02-04","current":-10.739283,"twenty":-28.373067,"median":-15.186632,"eighty":-12.971556,"marketCap":990709637},{"date":"2022-02-11","current":-11.841978,"twenty":-27.884642,"median":-15.154572,"eighty":-12.789242,"marketCap":1092434287},{"date":"2022-02-18","current":-12.213538,"twenty":-27.569868,"median":-15.134436,"eighty":-12.66337,"marketCap":1126711071},{"date":"2022-02-25","current":-13.543962,"twenty":-27.447762,"median":-15.081457,"eighty":-12.60844,"marketCap":1249444073},{"date":"2022-03-04","current":-12.902121,"twenty":-27.407317,"median":-15.056803,"eighty":-12.655185,"marketCap":1291205520},{"date":"2022-03-11","current":-13.667358,"twenty":-27.190856,"median":-15.039487,"eighty":-12.697912,"marketCap":1367788141},{"date":"2022-03-18","current":-14.629531,"twenty":-26.912591,"median":-15.031927,"eighty":-12.729886,"marketCap":1464079526},{"date":"2022-03-25","current":-13.481675,"twenty":-26.806708,"median":-15.008832,"eighty":-12.75445,"marketCap":1349205593},{"date":"2022-04-01","current":-13.397274,"twenty":-26.56186,"median":-15.002599,"eighty":-12.786391,"marketCap":1340758981},{"date":"2022-04-08","current":-14.438221,"twenty":-26.252858,"median":-14.954417,"eighty":-12.801505,"marketCap":1444933870},{"date":"2022-04-14","current":-13.802399,"twenty":-26.169603,"median":-14.89419,"eighty":-12.812618,"marketCap":1381302722},{"date":"2022-04-22","current":-14.501863,"twenty":-26.054435,"median":-14.847747,"eighty":-12.834599,"marketCap":1451302975},{"date":"2022-04-29","current":-14.043604,"twenty":-25.893476,"median":-14.832093,"eighty":-12.903035,"marketCap":1405441800},{"date":"2022-05-06","current":-14.078409,"twenty":-25.749169,"median":-14.8193,"eighty":-12.912799,"marketCap":1408924928},{"date":"2022-05-13","current":-11.643665,"twenty":-25.696441,"median":-14.803884,"eighty":-12.798225,"marketCap":1372124372},{"date":"2022-05-20","current":-12.974793,"twenty":-25.63955,"median":-14.78197,"eighty":-12.727529,"marketCap":1528988570},{"date":"2022-05-27","current":-12.910464,"twenty":-25.529933,"median":-14.739625,"eighty":-12.727529,"marketCap":1521407772},{"date":"2022-06-03","current":-10.83707,"twenty":-25.468879,"median":-14.701463,"eighty":-12.638816,"marketCap":1277072833},{"date":"2022-06-10","current":-9.322849,"twenty":-25.378687,"median":-14.632372,"eighty":-12.529434,"marketCap":1098632519},{"date":"2022-06-17","current":-9.990888,"twenty":-25.323184,"median":-14.567395,"eighty":-12.411304,"marketCap":1177356187},{"date":"2022-06-24","current":-9.649446,"twenty":-25.295433,"median":-14.559871,"eighty":-12.356612,"marketCap":1137119646},{"date":"2022-07-01","current":-10.733153,"twenty":-25.027632,"median":-14.544872,"eighty":-12.280659,"marketCap":1264826929},{"date":"2022-07-08","current":-11.802015,"twenty":-24.945765,"median":-14.531772,"eighty":-12.208936,"marketCap":1390784797},{"date":"2022-07-15","current":-12.316652,"twenty":-23.952679,"median":-14.512216,"eighty":-12.136983,"marketCap":1451431178},{"date":"2022-07-22","current":-11.287377,"twenty":-22.944874,"median":-14.465518,"eighty":-12.125268,"marketCap":1330138416},{"date":"2022-07-29","current":-11.420985,"twenty":-22.588047,"median":-14.443856,"eighty":-12.103448,"marketCap":1345883150},{"date":"2022-08-05","current":-12.831289,"twenty":-22.429865,"median":-14.436004,"eighty":-12.081262,"marketCap":1512077560},{"date":"2022-08-12","current":-10.957188,"twenty":-21.819211,"median":-14.406349,"eighty":-11.987006,"marketCap":1563546932},{"date":"2022-08-19","current":-10.807545,"twenty":-21.413336,"median":-14.344728,"eighty":-11.893983,"marketCap":1542193484},{"date":"2022-08-26","current":-11.55576,"twenty":-21.328727,"median":-14.308806,"eighty":-11.856598,"marketCap":1648960725},{"date":"2022-09-02","current":-10.965502,"twenty":-21.257607,"median":-14.253853,"eighty":-11.805991,"marketCap":1564733234},{"date":"2022-09-09","current":-11.759441,"twenty":-21.228177,"median":-14.197019,"eighty":-11.782001,"marketCap":1678025140},{"date":"2022-09-16","current":-10.861583,"twenty":-21.051603,"median":-14.162382,"eighty":-11.765767,"marketCap":1549904451},{"date":"2022-09-23","current":-10.325363,"twenty":-20.642048,"median":-14.149216,"eighty":-11.72881,"marketCap":1473387928},{"date":"2022-09-30","current":-9.976196,"twenty":-20.374734,"median":-14.130616,"eighty":-11.651023,"marketCap":1423563216},{"date":"2022-10-07","current":-10.00945,"twenty":-20.25334,"median":-14.108764,"eighty":-11.612104,"marketCap":1428308426},{"date":"2022-10-14","current":-10.208974,"twenty":-20.041205,"median":-14.087145,"eighty":-11.550385,"marketCap":1456779691},{"date":"2022-10-21","current":-8.554588,"twenty":-19.925941,"median":-14.050563,"eighty":-11.479299,"marketCap":1220705457},{"date":"2022-10-28","current":-23.436216,"twenty":-20.25334,"median":-14.078409,"eighty":-11.519454,"marketCap":3344254210},{"date":"2022-11-04","current":-23.236229,"twenty":-21.228177,"median":-14.098831,"eighty":-11.528532,"marketCap":3315716985},{"date":"2022-11-11","current":-20.162877,"twenty":-21.051603,"median":-14.115937,"eighty":-11.5396,"marketCap":3508300306},{"date":"2022-11-18","current":-19.99039,"twenty":-20.642048,"median":-14.139963,"eighty":-11.550385,"marketCap":3478287831},{"date":"2022-11-25","current":-19.972233,"twenty":-20.383318,"median":-14.156214,"eighty":-11.558496,"marketCap":3475128624},{"date":"2022-12-02","current":-20.385295,"twenty":-20.609529,"median":-14.168551,"eighty":-11.575016,"marketCap":3547000602},{"date":"2022-12-09","current":-19.241431,"twenty":-20.426561,"median":-14.229892,"eighty":-11.597521,"marketCap":3347970508},{"date":"2022-12-16","current":-20.789279,"twenty":-20.651289,"median":-14.285748,"eighty":-11.6052,"marketCap":3617292976},{"date":"2022-12-23","current":-21.184185,"twenty":-20.782016,"median":-14.325872,"eighty":-11.6332,"marketCap":3686005747},{"date":"2022-12-30","current":-21.765195,"twenty":-20.907297,"median":-14.359697,"eighty":-11.634738,"marketCap":3787100398},{"date":"2023-01-06","current":-21.175106,"twenty":-21.113374,"median":-14.412372,"eighty":-11.64188,"marketCap":3684426143},{"date":"2023-01-13","current":-20.25366,"twenty":-20.996264,"median":-14.438221,"eighty":-11.644103,"marketCap":3524096345},{"date":"2023-01-20","current":-20.471539,"twenty":-20.932716,"median":-14.443856,"eighty":-11.654429,"marketCap":3562006839},{"date":"2023-01-27","current":-20.957227,"twenty":-21.021683,"median":-14.465518,"eighty":-11.668106,"marketCap":3646515649},{"date":"2023-02-03","current":-20.539626,"twenty":-20.962674,"median":-14.501863,"eighty":-11.693283,"marketCap":3573853869},{"date":"2023-02-10","current":-19.858755,"twenty":-20.927269,"median":-14.524498,"eighty":-11.719479,"marketCap":3455383575},{"date":"2023-02-17","current":-20.072094,"twenty":-20.907297,"median":-14.544872,"eighty":-11.729321,"marketCap":3492504267},{"date":"2023-02-24","current":-18.92823,"twenty":-20.885509,"median":-14.550984,"eighty":-11.733669,"marketCap":3293474173},{"date":"2023-03-03","current":-15.234288,"twenty":-20.849196,"median":-14.56482,"eighty":-11.744206,"marketCap":3404634746},{"date":"2023-03-10","current":-13.543976,"twenty":-20.829775,"median":-14.567395,"eighty":-11.755294,"marketCap":3026875555},{"date":"2023-03-17","current":-13.461609,"twenty":-20.800999,"median":-14.555428,"eighty":-11.765767,"marketCap":3008467797},{"date":"2023-03-24","current":-13.551139,"twenty":-20.774754,"median":-14.544872,"eighty":-11.782001,"marketCap":3028476229},{"date":"2023-03-31","current":-13.422217,"twenty":-20.713022,"median":-14.524498,"eighty":-11.796077,"marketCap":2999664087},{"date":"2023-04-06","current":-13.475934,"twenty":-20.653105,"median":-14.50704,"eighty":-11.802778,"marketCap":3011669147},{"date":"2023-04-14","current":-13.074843,"twenty":-20.651289,"median":-14.481561,"eighty":-11.805884,"marketCap":2922031372},{"date":"2023-04-21","current":-18.52965,"twenty":-20.644026,"median":-14.496144,"eighty":-11.808405,"marketCap":4141098868},{"date":"2023-04-28","current":-17.350338,"twenty":-20.637671,"median":-14.522192,"eighty":-11.817795,"marketCap":3877540192},{"date":"2023-05-05","current":-20.292744,"twenty":-20.608621,"median":-14.540806,"eighty":-11.820768,"marketCap":4535123986},{"date":"2023-05-12","current":-18.764855,"twenty":-20.608621,"median":-14.550984,"eighty":-11.830425,"marketCap":4596657665},{"date":"2023-05-19","current":-18.602803,"twenty":-20.594096,"median":-14.562246,"eighty":-11.831705,"marketCap":4556961197},{"date":"2023-05-25","current":-19.486465,"twenty":-20.588649,"median":-14.567395,"eighty":-11.837869,"marketCap":4773423882},{"date":"2023-06-02","current":-19.241641,"twenty":-20.566861,"median":-14.631091,"eighty":-11.848868,"marketCap":4713451537},{"date":"2023-06-09","current":-19.494115,"twenty":-20.535087,"median":-14.653628,"eighty":-11.860631,"marketCap":4775298018},{"date":"2023-06-16","current":-19.94551,"twenty":-20.51693,"median":-14.700243,"eighty":-11.866344,"marketCap":4885872030},{"date":"2023-06-23","current":-20.683807,"twenty":-20.530548,"median":-14.717194,"eighty":-11.866918,"marketCap":5066726135},{"date":"2023-06-30","current":-18.556898,"twenty":-20.521469,"median":-14.735995,"eighty":-11.867493,"marketCap":4545716382},{"date":"2023-07-07","current":-17.986917,"twenty":-20.50876,"median":-14.751068,"eighty":-11.869888,"marketCap":4406093265},{"date":"2023-07-14","current":-18.530121,"twenty":-20.492419,"median":-14.775826,"eighty":-11.883169,"marketCap":4539156907},{"date":"2023-07-21","current":-18.308249,"twenty":-20.476986,"median":-14.795999,"eighty":-11.893983,"marketCap":4484806969},{"date":"2023-07-28","current":-17.684713,"twenty":-20.449751,"median":-14.806507,"eighty":-11.917488,"marketCap":4332064901},{"date":"2023-08-04","current":-18.675485,"twenty":-20.429779,"median":-14.847747,"eighty":-11.938838,"marketCap":4574765487},{"date":"2023-08-11","current":-16.822179,"twenty":-20.409807,"median":-14.877903,"eighty":-11.965282,"marketCap":4453974775},{"date":"2023-08-18","current":-16.808001,"twenty":-20.39619,"median":-14.922726,"eighty":-11.987006,"marketCap":4450220898},{"date":"2023-08-25","current":-17.499178,"twenty":-20.39289,"median":-14.955882,"eighty":-12.021492,"marketCap":4633222391},{"date":"2023-09-01","current":-18.403025,"twenty":-20.387937,"median":-15.002599,"eighty":-12.049146,"marketCap":4872532034},{"date":"2023-09-08","current":-17.65868,"twenty":-20.370771,"median":-15.005716,"eighty":-12.05623,"marketCap":4675453504},{"date":"2023-09-15","current":-18.254156,"twenty":-20.34457,"median":-15.02393,"eighty":-12.07384,"marketCap":4833116328},{"date":"2023-09-22","current":-18.498726,"twenty":-20.336915,"median":-15.038325,"eighty":-12.101,"marketCap":4897870702},{"date":"2023-09-29","current":-17.793371,"twenty":-20.329918,"median":-15.05078,"eighty":-12.110314,"marketCap":4711115333},{"date":"2023-10-05","current":-16.981682,"twenty":-20.318417,"median":-15.056803,"eighty":-12.11436,"marketCap":4496205889},{"date":"2023-10-13","current":-16.074291,"twenty":-20.302625,"median":-15.087198,"eighty":-12.118714,"marketCap":4255957776},{"date":"2023-10-20","current":-16.481908,"twenty":-20.286743,"median":-15.148339,"eighty":-12.120899,"marketCap":4363881733},{"date":"2023-10-27","current":-17.109284,"twenty":-20.27474,"median":-15.149846,"eighty":-12.125268,"marketCap":4529990780},{"date":"2023-11-03","current":-16.942692,"twenty":-20.257291,"median":-15.15932,"eighty":-12.136983,"marketCap":4485882728},{"date":"2023-11-10","current":-15.261986,"twenty":-20.237319,"median":-15.186632,"eighty":-12.142826,"marketCap":4571193788},{"date":"2023-11-17","current":-15.913257,"twenty":-20.193743,"median":-15.226852,"eighty":-12.158302,"marketCap":4766259301},{"date":"2023-11-24","current":-15.671811,"twenty":-20.168324,"median":-15.249734,"eighty":-12.181733,"marketCap":4693942330},{"date":"2023-12-01","current":-16.446982,"twenty":-20.146536,"median":-15.273621,"eighty":-12.206635,"marketCap":4926117868},{"date":"2023-12-08","current":-18.038626,"twenty":-20.120209,"median":-15.310702,"eighty":-12.223784,"marketCap":5402838953},{"date":"2023-12-15","current":-19.249037,"twenty":-20.114441,"median":-15.345894,"eighty":-12.244421,"marketCap":5765375346},{"date":"2023-12-22","current":-18.858274,"twenty":-20.094761,"median":-15.397427,"eighty":-12.255986,"marketCap":5648336038},{"date":"2023-12-29","current":-20.113163,"twenty":-20.109873,"median":-15.413482,"eighty":-12.261481,"marketCap":6024193978},{"date":"2024-01-05","current":-20.440387,"twenty":-20.111189,"median":-15.447202,"eighty":-12.270831,"marketCap":6122202505},{"date":"2024-01-12","current":-19.061598,"twenty":-20.087206,"median":-15.502485,"eighty":-12.282097,"marketCap":5709234540},{"date":"2024-01-19","current":-19.32846,"twenty":-20.064832,"median":-15.526575,"eighty":-12.296687,"marketCap":5789163823},{"date":"2024-01-26","current":-20.141755,"twenty":-20.103564,"median":-15.604871,"eighty":-12.314783,"marketCap":6032757830},{"date":"2024-02-02","current":-26.753532,"twenty":-20.133863,"median":-15.653053,"eighty":-12.324561,"marketCap":8013084121},{"date":"2024-02-09","current":-26.696296,"twenty":-20.242766,"median":-15.671811,"eighty":-12.343291,"marketCap":7995941244},{"date":"2024-02-16","current":-27.009566,"twenty":-20.315086,"median":-15.741703,"eighty":-12.355101,"marketCap":8089770067},{"date":"2024-02-23","current":-26.599075,"twenty":-20.346777,"median":-15.756821,"eighty":-12.358131,"marketCap":7966821955},{"date":"2024-03-01","current":-19.791455,"twenty":-20.39058,"median":-15.767484,"eighty":-12.362433,"marketCap":7961429494},{"date":"2024-03-08","current":-19.338793,"twenty":-20.378033,"median":-15.787476,"eighty":-12.370073,"marketCap":7779338704},{"date":"2024-03-15","current":-18.670451,"twenty":-20.346777,"median":-15.797598,"eighty":-12.386838,"marketCap":7510487534},{"date":"2024-03-22","current":-18.228483,"twenty":-20.337432,"median":-15.827712,"eighty":-12.411509,"marketCap":7332698857},{"date":"2024-03-28","current":-18.460246,"twenty":-20.335365,"median":-15.836525,"eighty":-12.412327,"marketCap":7425929505},{"date":"2024-04-05","current":-17.075054,"twenty":-20.321747,"median":-15.83959,"eighty":-12.439419,"marketCap":6868713772},{"date":"2024-04-12","current":-17.471208,"twenty":-20.305095,"median":-15.881916,"eighty":-12.458883,"marketCap":7028073135},{"date":"2024-04-19","current":-16.389647,"twenty":-20.292744,"median":-15.911669,"eighty":-12.479472,"marketCap":6592997737},{"date":"2024-04-26","current":-16.238241,"twenty":-20.262738,"median":-15.930098,"eighty":-12.504692,"marketCap":6532092446},{"date":"2024-05-03","current":-17.452189,"twenty":-20.25366,"median":-15.962149,"eighty":-12.529434,"marketCap":7020422368},{"date":"2024-05-10","current":-16.330835,"twenty":-20.226425,"median":-15.977539,"eighty":-12.570574,"marketCap":7133700477},{"date":"2024-05-17","current":-18.791543,"twenty":-20.171955,"median":-16.02345,"eighty":-12.576745,"marketCap":8208596934},{"date":"2024-05-24","current":-17.252355,"twenty":-20.162877,"median":-16.044981,"eighty":-12.588189,"marketCap":7536242672},{"date":"2024-05-31","current":-17.486471,"twenty":-20.145979,"median":-16.069505,"eighty":-12.628691,"marketCap":7638510149},{"date":"2024-06-07","current":-18.059308,"twenty":-20.138199,"median":-16.100696,"eighty":-12.670073,"marketCap":7888739081},{"date":"2024-06-14","current":-18.432897,"twenty":-20.128139,"median":-16.153211,"eighty":-12.677887,"marketCap":8051931863},{"date":"2024-06-21","current":-18.121573,"twenty":-20.120209,"median":-16.193449,"eighty":-12.678628,"marketCap":7915937878},{"date":"2024-06-28","current":-19.618421,"twenty":-20.118394,"median":-16.224679,"eighty":-12.679369,"marketCap":8569796958},{"date":"2024-07-05","current":-18.993281,"twenty":-20.114892,"median":-16.24076,"eighty":-12.706999,"marketCap":8296721036},{"date":"2024-07-12","current":-20.412921,"twenty":-20.128139,"median":-16.30313,"eighty":-12.732244,"marketCap":8916853608},{"date":"2024-07-15","current":-20.520016,"twenty":-20.138199,"median":-16.303907,"eighty":-12.734601,"marketCap":8963635539},{"date":"2024-08-02","current":-19.57359,"twenty":-20.13731,"median":-16.304683,"eighty":-12.736958,"marketCap":8550213824},{"date":"2024-08-09","current":-16.530842,"twenty":-20.122025,"median":-16.304683,"eighty":-12.780687,"marketCap":8218936172},{"date":"2024-08-16","current":-17.608355,"twenty":-20.117486,"median":-16.330835,"eighty":-12.794946,"marketCap":8754662593},{"date":"2024-08-23","current":-17.54101,"twenty":-20.113163,"median":-16.355854,"eighty":-12.79665,"marketCap":8721179691},{"date":"2024-08-30","current":-17.796919,"twenty":-20.109873,"median":-16.382189,"eighty":-12.811343,"marketCap":8848414716},{"date":"2024-09-06","current":-25.164413,"twenty":-20.118394,"median":-16.416684,"eighty":-12.816444,"marketCap":12511444119},{"date":"2024-09-13","current":-28.394781,"twenty":-20.157687,"median":-16.444961,"eighty":-12.828575,"marketCap":14117544202},{"date":"2024-09-20","current":-29.138673,"twenty":-20.231872,"median":-16.459942,"eighty":-12.887955,"marketCap":14487398378},{"date":"2024-09-27","current":-27.725527,"twenty":-20.308425,"median":-16.491202,"eighty":-12.905778,"marketCap":13784799140},{"date":"2024-10-04","current":-27.635961,"twenty":-20.356246,"median":-16.541596,"eighty":-12.90971,"marketCap":13740268202},{"date":"2024-10-11","current":-27.765334,"twenty":-20.401715,"median":-16.572344,"eighty":-12.931873,"marketCap":13804590668},{"date":"2024-10-18","current":-28.762995,"twenty":-20.436258,"median":-16.616599,"eighty":-12.959362,"marketCap":14300615834},{"date":"2024-10-25","current":-27.944465,"twenty":-20.506036,"median":-16.648008,"eighty":-12.966906,"marketCap":13893652543},{"date":"2024-10-31","current":-26.399458,"twenty":-20.557783,"median":-16.667668,"eighty":-12.971839,"marketCap":13125493869},{"date":"2024-11-08","current":-25.214663,"twenty":-20.644026,"median":-16.733567,"eighty":-12.983254,"marketCap":12800173274},{"date":"2024-11-15","current":-22.754576,"twenty":-20.684289,"median":-16.791289,"eighty":-12.992224,"marketCap":11551315083},{"date":"2024-11-22","current":-21.701305,"twenty":-20.822787,"median":-16.813646,"eighty":-12.995724,"marketCap":11016624300},{"date":"2024-11-29","current":-23.162135,"twenty":-20.907297,"median":-16.822179,"eighty":-13.001558,"marketCap":11758211749},{"date":"2024-12-06","current":-22.10641,"twenty":-21.101995,"median":-16.843442,"eighty":-13.013917,"marketCap":11222274601},{"date":"2024-12-13","current":-21.573636,"twenty":-21.189632,"median":-16.875347,"eighty":-13.021971,"marketCap":10951813297},{"date":"2024-12-20","current":-21.166077,"twenty":-21.226278,"median":-16.929408,"eighty":-13.028697,"marketCap":10744916630},{"date":"2024-12-27","current":-21.060504,"twenty":-21.23055,"median":-16.99586,"eighty":-13.041117,"marketCap":10691322915},{"date":"2025-01-03","current":-20.451621,"twenty":-21.213463,"median":-17.04371,"eighty":-13.056938,"marketCap":10382224281},{"date":"2025-01-10","current":-19.901661,"twenty":-21.217735,"median":-17.069181,"eighty":-13.068397,"marketCap":10103038418},{"date":"2025-01-17","current":-21.563816,"twenty":-21.235455,"median":-17.105654,"eighty":-13.074127,"marketCap":10946827835},{"date":"2025-01-24","current":-22.090451,"twenty":-21.246134,"median":-17.110391,"eighty":-13.076047,"marketCap":11214173226},{"date":"2025-01-31","current":-22.575348,"twenty":-21.285242,"median":-17.144092,"eighty":-13.080045,"marketCap":11460330404},{"date":"2025-02-07","current":-21.854754,"twenty":-21.34285,"median":-17.212623,"eighty":-13.093733,"marketCap":11094522142},{"date":"2025-02-14","current":-20.5842,"twenty":-21.34285,"median":-17.248595,"eighty":-13.124157,"marketCap":10449528016},{"date":"2025-02-21","current":-20.247841,"twenty":-21.305793,"median":-17.268422,"eighty":-13.140798,"marketCap":10278775948},{"date":"2025-02-28","current":-20.59955,"twenty":-21.28584,"median":-17.296089,"eighty":-13.151072,"marketCap":9556687584},{"date":"2025-03-07","current":-20.763303,"twenty":-21.279088,"median":-17.346779,"eighty":-13.166601,"marketCap":9632656941},{"date":"2025-03-14","current":-20.266494,"twenty":-21.271161,"median":-17.38221,"eighty":-13.175744,"marketCap":9402173638},{"date":"2025-03-21","current":-20.666162,"twenty":-21.261605,"median":-17.434922,"eighty":-13.187616,"marketCap":9587590374},{"date":"2025-03-28","current":-19.642013,"twenty":-21.246879,"median":-17.48489,"eighty":-13.202598,"marketCap":9112459988},{"date":"2025-04-04","current":-8.481841,"twenty":-21.24317,"median":-17.461699,"eighty":-13.166601,"marketCap":3934955168},{"date":"2025-04-11","current":-7.782422,"twenty":-21.239771,"median":-17.384971,"eighty":-13.08988,"marketCap":3610475880},{"date":"2025-04-17","current":-8.082173,"twenty":-21.237354,"median":-17.363411,"eighty":-13.071978,"marketCap":3749538432},{"date":"2025-04-25","current":-9.578153,"twenty":-21.23055,"median":-17.338853,"eighty":-13.021611,"marketCap":4443563575},{"date":"2025-05-02","current":-9.79882,"twenty":-21.209423,"median":-17.273877,"eighty":-12.990005,"marketCap":4545937129},{"date":"2025-05-09","current":-7.961109,"twenty":-21.191447,"median":-17.258708,"eighty":-12.942759,"marketCap":4057180140},{"date":"2025-05-16","current":-7.821884,"twenty":-21.182369,"median":-17.225081,"eighty":-12.845455,"marketCap":3986227864},{"date":"2025-05-23","current":-8.593947,"twenty":-21.1733,"median":-17.165551,"eighty":-12.795287,"marketCap":4379690485},{"date":"2025-05-30","current":-8.302842,"twenty":-21.166077,"median":-17.133888,"eighty":-12.725172,"marketCap":4231335726},{"date":"2025-06-06","current":-8.809113,"twenty":-21.132441,"median":-17.109284,"eighty":-12.638816,"marketCap":4489344002},{"date":"2025-06-13","current":-8.723047,"twenty":-21.131367,"median":-17.105654,"eighty":-12.581323,"marketCap":4445482595},{"date":"2025-06-20","current":-8.454723,"twenty":-21.099418,"median":-17.04371,"eighty":-12.484516,"marketCap":4308738209},{"date":"2025-06-27","current":-8.323093,"twenty":-21.036935,"median":-16.897568,"eighty":-12.386838,"marketCap":4241656057},{"date":"2025-07-03","current":-8.416753,"twenty":-20.935584,"median":-16.843442,"eighty":-12.354346,"marketCap":4289387588},{"date":"2025-07-11","current":-9.173628,"twenty":-20.851011,"median":-16.810823,"eighty":-12.278742,"marketCap":4675109961},{"date":"2025-07-18","current":-9.459671,"twenty":-20.784084,"median":-16.720351,"eighty":-12.204334,"marketCap":4820884637},{"date":"2025-07-25","current":-9.173628,"twenty":-20.68477,"median":-16.635317,"eighty":-12.120899,"marketCap":4675109961},{"date":"2025-08-01","current":-8.593947,"twenty":-20.644026,"median":-16.553858,"eighty":-12.066419,"marketCap":4379690485},{"date":"2025-08-08","current":-7.116045,"twenty":-20.598459,"median":-16.480136,"eighty":-11.950749,"marketCap":3895998883},{"date":"2025-08-15","current":-7.452759,"twenty":-20.519399,"median":-16.437368,"eighty":-11.868483,"marketCap":4080348047},{"date":"2025-08-22","current":-7.566577,"twenty":-20.482433,"median":-16.366967,"eighty":-11.830425,"marketCap":4142663258},{"date":"2025-08-29","current":-7.296258,"twenty":-20.434352,"median":-16.309999,"eighty":-11.802778,"marketCap":3994664633},{"date":"2025-09-05","current":-7.623487,"twenty":-20.394374,"median":-16.243279,"eighty":-11.75253,"marketCap":4173820863},{"date":"2025-09-12","current":-7.839268,"twenty":-20.337432,"median":-16.175585,"eighty":-11.67955,"marketCap":4291960116},{"date":"2025-09-19","current":-7.727821,"twenty":-20.287494,"median":-16.074786,"eighty":-11.6332,"marketCap":4230943139},{"date":"2025-09-26","current":-7.621115,"twenty":-20.247841,"median":-16.038507,"eighty":-11.548594,"marketCap":4172522629},{"date":"2025-10-03","current":-9.515724,"twenty":-20.161579,"median":-15.967748,"eighty":-11.435788,"marketCap":5209811236},{"date":"2025-10-10","current":-9.956772,"twenty":-20.121117,"median":-15.919611,"eighty":-11.377135,"marketCap":5451282676},{"date":"2025-10-17","current":-10.336168,"twenty":-20.092195,"median":-15.848787,"eighty":-11.300594,"marketCap":5659000044},{"date":"2025-10-24","current":-9.864294,"twenty":-20.052985,"median":-15.830426,"eighty":-11.247666,"marketCap":5400651568},{"date":"2025-10-31","current":-10.61123,"twenty":-19.995479,"median":-15.795066,"eighty":-11.085574,"marketCap":5809595136},{"date":"2025-11-07","current":-8.308113,"twenty":-19.989732,"median":-15.765218,"eighty":-10.958851,"marketCap":5460100229},{"date":"2025-11-14","current":-9.072993,"twenty":-19.958021,"median":-15.674477,"eighty":-10.876553,"marketCap":5962780279},{"date":"2025-11-21","current":-9.495271,"twenty":-19.924444,"median":-15.629917,"eighty":-10.841973,"marketCap":6240301557},{"date":"2025-11-28","current":-9.881695,"twenty":-19.875402,"median":-15.51453,"eighty":-10.813365,"marketCap":6494259707},{"date":"2025-12-05","current":-9.176571,"twenty":-19.875402,"median":-15.428809,"eighty":-10.769092,"marketCap":6030851536},{"date":"2025-12-12","current":-8.881773,"twenty":-19.856979,"median":-15.337298,"eighty":-10.735643,"marketCap":5837110267},{"date":"2025-12-19","current":-8.706488,"twenty":-19.825078,"median":-15.267803,"eighty":-10.690375,"marketCap":5721912755},{"date":"2025-12-26","current":-9.491287,"twenty":-19.825078,"median":-15.226852,"eighty":-10.643534,"marketCap":6237683431},{"date":"2026-01-02","current":-9.190514,"twenty":-19.825078,"median":-15.171582,"eighty":-10.613914,"marketCap":6040014974},{"date":"2026-01-09","current":-9.02718,"twenty":-19.825078,"median":-15.141388,"eighty":-10.565682,"marketCap":5932671839},{"date":"2026-01-16","current":-9.56897,"twenty":-19.825078,"median":-15.056803,"eighty":-10.48168,"marketCap":6288736874},{"date":"2026-01-23","current":-10.722266,"twenty":-19.825078,"median":-15.039487,"eighty":-10.426172,"marketCap":7046684137},{"date":"2026-01-30","current":-10.521087,"twenty":-19.825078,"median":-15.022512,"eighty":-10.41063,"marketCap":6914468811},{"date":"2026-02-06","current":-11.775877,"twenty":-19.825078,"median":-15.002599,"eighty":-10.41063,"marketCap":7739118138},{"date":"2026-02-13","current":-12.00305,"twenty":-19.825078,"median":-14.938572,"eighty":-10.41063,"marketCap":7888416651},{"date":"2026-02-20","current":-12.520743,"twenty":-19.825078,"median":-14.868084,"eighty":-10.41063,"marketCap":8228644995},{"date":"2026-02-27","current":-11.263901,"twenty":-19.825078,"median":-14.836493,"eighty":-10.41063,"marketCap":8635221660},{"date":"2026-03-06","current":-10.93537,"twenty":-19.825078,"median":-14.789855,"eighty":-10.41063,"marketCap":8383361028},{"date":"2026-03-13","current":-10.552398,"twenty":-19.825078,"median":-14.736275,"eighty":-10.41063,"marketCap":8089763491},{"date":"2026-03-20","current":-10.133756,"twenty":-19.825078,"median":-14.633932,"eighty":-10.387838,"marketCap":7768821086},{"date":"2026-03-27","current":-10.2708,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"marketCap":7873882950},{"date":"2026-04-02","current":-10.982303,"twenty":-19.825078,"median":-14.631091,"eighty":-10.355291,"marketCap":8419341118},{"date":"2026-04-10","current":-11.581167,"twenty":-19.825078,"median":-14.631091,"eighty":-10.355291,"marketCap":8878447070},{"date":"2026-04-17","current":-11.67691,"twenty":-19.825078,"median":-14.631091,"eighty":-10.355291,"marketCap":8951846454},{"date":"2026-04-24","current":-11.408454,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"marketCap":8746040337},{"date":"2026-05-01","current":-10.780619,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"marketCap":8264724759},{"date":"2026-05-08","current":-7.852935,"twenty":-19.825078,"median":-14.631091,"eighty":-10.387838,"marketCap":7433054343},{"date":"2026-05-15","current":-8.16624,"twenty":-19.825078,"median":-14.631091,"eighty":-10.359343,"marketCap":7729607917},{"date":"2026-05-22","current":-7.229556,"twenty":-19.825078,"median":-14.631091,"eighty":-10.320728,"marketCap":6843006149},{"date":"2026-05-29","current":-7.789431,"twenty":-19.83248,"median":-14.632651,"eighty":-10.272677,"marketCap":7372945642},{"date":"2026-06-05","current":-7.438556,"twenty":-19.825078,"median":-14.631091,"eighty":-10.234464,"marketCap":7040830974},{"date":"2026-06-12","current":-7.214301,"twenty":-19.825078,"median":-14.595889,"eighty":-10.172838,"marketCap":6828566381},{"date":"2026-06-18","current":-7.729935,"twenty":-19.825078,"median":-14.595889,"eighty":-10.15146,"marketCap":7316630546},{"date":"2026-06-26","current":-8.189124,"twenty":-19.83248,"median":-14.562246,"eighty":-10.071801,"marketCap":7751267569},{"date":"2026-07-02","current":-8.555254,"twenty":-19.83248,"median":-14.559871,"eighty":-10.00945,"marketCap":8097822006},{"date":"2026-07-10","current":-9.127334,"twenty":-19.83248,"median":-14.559871,"eighty":-9.979816,"marketCap":8639313314},{"date":"2026-07-17","current":-8.549152,"twenty":-19.83248,"median":-14.559871,"eighty":-9.928317,"marketCap":8092046099},{"date":"2026-07-24","current":-8.48813,"twenty":-19.83248,"median":-14.559871,"eighty":-9.864294,"marketCap":8034287026},{"date":"2026-07-31","current":-8.536948,"twenty":-19.835244,"median":-14.561058,"eighty":-9.798636,"marketCap":8080494284},{"date":"2026-08-07","current":-7.990126,"twenty":-19.835244,"median":-14.544872,"eighty":-9.695653,"marketCap":8503579492},{"date":"2026-08-14","current":-8.229822,"twenty":-19.835244,"median":-14.46995,"eighty":-9.645302,"marketCap":8758678663},{"date":"2026-08-21","current":-8.576576,"twenty":-19.835244,"median":-14.441039,"eighty":-9.528943,"marketCap":9127715752}],"updateTime":1787583266152},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCVX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627285686","title":"Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and Vaxcyte (PCVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627285686","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627285686?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:40","pubTimestamp":1776249615,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and V...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-merit-medical-systems-mmsi-and-vaxcyte-pcvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-merit-medical-systems-mmsi-and-vaxcyte-pcvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LABU","XBI","IE0009354923.USD","RCKT","XLV","LU1559883803.SGD","MMSI","PCVX","BK4585","LU0053671581.USD","HCSG","BK4139","BK4198","LU0029874061.USD","BK4588","LU0566484027.USD","LU0128526141.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626922799","title":"Vaxcyte SVP Finance Elvia Cowan disposes of USD 180,000 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2626922799","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626922799?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:33","pubTimestamp":1775680405,"startTime":"0","endTime":"0","summary":"Vaxcyte SVP, Finance & CAO Elvia Cowan sold 3,000 shares on April 7 at USD 60.She exercised options for 3,000 shares on April 7 at USD 25.92.Directly held common stock position stood at 28,975 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLbVTVkN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte SVP Finance Elvia Cowan disposes of USD 180,000 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4139","LU0053671581.USD","PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625696516","title":"Vaxcyte to present at Needham Virtual Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2625696516","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625696516?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:06","pubTimestamp":1775592391,"startTime":"0","endTime":"0","summary":"Vaxcyte management will join a fireside chat at Needham 25th Annual Virtual Healthcare Conference on April 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL7B3RCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","BK4585","BK4139","PCVX","SG9999014039.USD","SG9999014005.SGD","LU2095319765.USD","IE0009354923.USD","BK4588","IE00BN0W2V16.EUR","LU0053671581.USD","IE00B3QW5Z07.USD","NDAQ","LU2210150020.SGD","LU2210149790.SGD","LU0314104364.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625611939","title":"Vaxcyte (PCVX) Valuation Check As VAX-31 Phase 3 OPUS Trials Reach Full Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2625611939","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625611939?lang=en_us&edition=fundamental","pubTime":"2026-04-05 02:14","pubTimestamp":1775326450,"startTime":"0","endTime":"0","summary":"Vaxcyte (PCVX) recently reported full enrollment in its OPUS-1 and OPUS-2 Phase 3 trials for VAX-31, a key step toward a potential Biologics License Application that investors often monitor closely.\nSee our latest analysis for Vaxcyte.\nThe recent completion of enrollment in the OPUS-1 and OPUS-2 trials comes alongside strong momentum, with a 90 day share price return of 25.66% and a 1 year total shareholder return of 84.75%, while the latest share price stands at US$58.38.\nIf this kind of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-valuation-check-as-vax-31-phase-3-opus-trials-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-valuation-check-as-vax-31-phase-3-opus-trials-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PCVX","LU0053671581.USD","BK4139","OPUS","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624664866","title":"Vaxcyte COO Jim Wassil disposes of common shares worth $0.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624664866","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624664866?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:06","pubTimestamp":1775246806,"startTime":"0","endTime":"0","summary":"Vaxcyte COO Jim Wassil sold 2,250 shares on April 1, 2026.Sales totaled about $0.1 million at weighted-average prices of $58.14 and $58.93 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL1S98yJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte COO Jim Wassil disposes of common shares worth $0.1 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622078867","title":"Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078867","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078867?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:30","pubTimestamp":1774438229,"startTime":"0","endTime":"0","summary":"Vera Therapeutics appointed Jane Wright-Mitchell as Chief Legal Officer, effective immediately.Wright-Mitchell previously served as a fractional general counsel supporting public and private life sciences companies.Her prior roles include General Counsel, Chief Compliance Officer and Corporate Secretary at Vaxcyte, and Chief Legal Officer positions at other pharmaceutical and research companies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL5FDKSy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BKPKM429.USD","BK4539","BK4112","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","LU0053671581.USD","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","VERA","LU0314104364.USD","PCVX","SG9999014013.SGD","BK4139","LU2324357040.USD","SG9999014021.USD","SG9999014005.SGD","IE0009354923.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621970553","title":"Vaxcyte completes enrollment in OPUS-1 and OPUS-2 Phase 3 trials of VAX-31 in about 5,300 adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2621970553","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621970553?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:31","pubTimestamp":1774269076,"startTime":"0","endTime":"0","summary":"Vaxcyte reported that enrollment is complete in the OPUS-1 Phase 3 trial of VAX-31 with about 4,000 participants and the OPUS-2 Phase 3 trial with about 1,300 participants.OPUS-1 is a randomized, double-blind, active-controlled noninferiority study comparing VAX-31 with Capvaxive  and Prevnar 20  in pneumococcal-nave adults ages 50 and older, with a separate cohort ages 18–49.Participants ages 50 and older were randomized 1:1:1 to VAX-31, PCV21, or PCV20, while adults ages 18–49 were randomized 3:1 to VAX-31 or PCV20.Topline safety, tolerability, and immunogenicity results from OPUS-1 are expected in the fourth quarter of 2026.OPUS-2 is evaluating concomitant administration of VAX-31 with a seasonal influenza vaccine, with results expected in the first half of 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL2YY9Xl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","NDAQ","IE00BN0W2W23.USD","PCVX","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","SG9999014013.SGD","BK4112","LU2210149790.SGD","BK4588","LU0053671581.USD","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","IE0009354923.USD","IE00B64PRP62.GBP","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621055337","title":"Vaxcyte Inc - Opus-3 Phase 3 Results Expected in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621055337?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nTUA1RWLJ1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","BK4139","LU0053671581.USD","PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621670562","title":"Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2621670562","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621670562?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269000,"startTime":"0","endTime":"0","summary":"OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with Capva","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260381/0/en/Vaxcyte-Completes-Enrollment-of-OPUS-1-and-OPUS-2-Phase-3-Trials-Evaluating-VAX-31-for-the-Prevention-of-Invasive-Pneumococcal-Disease-and-Pneumonia-in-Adults.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","PD","OPUS","LB","LU1169590202.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4585","CI","BK4588","BK4233","IE0002270589.USD","BK4023","LU0053671581.USD","LU0289739699.SGD","LU0058720904.USD","LU0868494617.USD","BK4139","IE00B19Z3581.USD","PCVX","LU1059921491.USD","IE0009354923.USD","LU1169589451.USD","LU1261432733.SGD","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621718060","title":"Will VAX-31’s Phase 3 OPUS Progress and Broader Serotype Coverage Change Vaxcyte’s (PCVX) Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2621718060","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621718060?lang=en_us&edition=fundamental","pubTime":"2026-03-22 10:12","pubTimestamp":1774145542,"startTime":"0","endTime":"0","summary":"Vaxcyte recently reported in The Lancet Infectious Diseases that its 31-valent pneumococcal conjugate vaccine candidate VAX-31 showed strong immune responses and a safety profile similar to Prevnar 20 in a Phase 1/2 study of 1,015 adults aged 50 and older, and has since advanced the high-dose regimen into the OPUS Phase 3 adult program.\nAn important insight from these data is that VAX-31 met or exceeded regulatory immunogenicity criteria for all 31 serotypes at higher doses while covering...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/will-vax-31s-phase-3-opus-progress-and-broader-serotype-cove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/will-vax-31s-phase-3-opus-progress-and-broader-serotype-cove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","BK4097","BK4139","PCVX","PRGS","LU2065732104.USD","OPUS","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621503407","title":"Assessing Vaxcyte (PCVX) Valuation After Strong VAX 31 Phase 1/2 Results In The Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2621503407","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621503407?lang=en_us&edition=fundamental","pubTime":"2026-03-21 07:12","pubTimestamp":1774048368,"startTime":"0","endTime":"0","summary":"Vaxcyte (PCVX) is back in focus after publishing VAX-31 Phase 1/2 results in The Lancet Infectious Diseases. The data show favorable safety and immune responses versus Prevnar 20 and support progression into broad Phase 3 trials.\nSee our latest analysis for Vaxcyte.\nThe VAX-31 update comes after a mixed period for investors, with a 90-day share price return of 17.73% and a 1-year total shareholder return decline of 26.8%, while the 5-year total shareholder return of 130.01% points to stronger...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/assessing-vaxcyte-pcvx-valuation-after-strong-vax-31-phase-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/assessing-vaxcyte-pcvx-valuation-after-strong-vax-31-phase-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PCVX","BK4139","IE0009354923.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620087296","title":"Vaxcyte reports positive VAX-31 phase 1/2 adult data published in The Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2620087296","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620087296?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:45","pubTimestamp":1773877517,"startTime":"0","endTime":"0","summary":"The company states: “Vaxcyte (PCVX) announced the publication of results from the positive VAX-31 adult Phase 1/2 clinical study in the journal The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vaxcyte-reports-positive-vax-31-phase-1-2-adult-data-published-in-the-lancet-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vaxcyte-reports-positive-vax-31-phase-1-2-adult-data-published-in-the-lancet-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009354923.USD","LU0053671581.USD","PCVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620296657","title":"Vaxcyte Inc - Publishes Positive Vax-31 Phase 1/2 Adult Study Results in the Lancet Infectious Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2620296657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620296657?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:35","pubTimestamp":1773876912,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40617R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","PCVX","IE0009354923.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620296650","title":"Vaxcyte Inc - Study Results Showed That Vax-31 Was Observed to Be Well Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2620296650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620296650?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:35","pubTimestamp":1773876912,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40617R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620572296","title":"Vaxcyte reports Phase 1/2 adult data showing VAX-31 met noninferiority to Prevnar 20 and achieved ~95% IPD coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2620572296","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620572296?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:34","pubTimestamp":1773876869,"startTime":"0","endTime":"0","summary":"Vaxcyte reported that results from a Phase 1/2 adult study of its 31-valent pneumococcal conjugate vaccine candidate VAX-31 were published in The Lancet Infectious Diseases. In adults aged 50 and older, VAX-31 was evaluated for safety, tolerability, and immunogenicity versus Prevnar 20, and it showed robust opsonophagocytic activity and IgG responses across 31 serotypes. Vaxcyte said the VAX-31 High Dose met noninferiority criteria for 20 serotypes shared with Prevnar 20 and met superiority criteria for 11 additional serotypes not included in Prevnar 20. Based on these results, the company advanced VAX-31 High Dose into its OPUS Phase 3 adult program, with topline data from the OPUS-1 pivotal noninferiority trial expected in Q4 2026. The Phase 3 program includes head-to-head comparisons versus Prevnar 20 and Capvaxive.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL99Fmtv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0053671581.USD","PCVX","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","IE0009354923.USD","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620295435","title":"Vaxcyte SVP Finance and CAO Elvia Cowan disposes of USD 104,979 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620295435","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620295435?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:04","pubTimestamp":1773875047,"startTime":"0","endTime":"0","summary":"Elvia Cowan, SVP, Finance and CAO of Vaxcyte, reported sales of 1,487 common shares on March 17, 2026. Cowan also sold 405 common shares at a weighted-average price of USD 56.26. Following the transactions, Cowan reported beneficial ownership of 28,975 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1WsdDz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte SVP Finance and CAO Elvia Cowan disposes of USD 104,979 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX","IE0009354923.USD","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618976073","title":"Vaxcyte COO Jim Wassil Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2618976073","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618976073?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:24","pubTimestamp":1773264256,"startTime":"0","endTime":"0","summary":"Jim Wassil, Chief Operating Officer of Vaxcyte, Inc., reported a disposal of the company’s common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL97xhMt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte COO Jim Wassil Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009354923.USD","LU0053671581.USD","PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616816398","title":"Vaxcyte Earnings Call: Cash Strength, Trials Accelerate","url":"https://stock-news.laohu8.com/highlight/detail?id=2616816398","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616816398?lang=en_us&edition=fundamental","pubTime":"2026-03-03 08:18","pubTimestamp":1772497081,"startTime":"0","endTime":"0","summary":"Vaxcyte, Inc. (($PCVX)) has held its Q4 earnings call. Read on for the main highlights of the call. Vaxcyte’s latest earnings call painted a notabl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vaxcyte-earnings-call-cash-strength-trials-accelerate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vaxcyte-earnings-call-cash-strength-trials-accelerate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX","AAQC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616827002","title":"Vaxcyte (PCVX) Is Up 5.5% After Unveiling VAX-31 Data, Phase 3 Plans And New Financing - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616827002","media":"Simply Wall St.","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616827002?lang=en_us&edition=fundamental","pubTime":"2026-03-01 19:20","pubTimestamp":1772364038,"startTime":"0","endTime":"0","summary":"In February 2026, Vaxcyte reported a full-year 2025 net loss of US$766.63 million and higher loss per share, while also raising roughly US$408.10 million through an at-the-market follow-on equity offering and filing additional shelf capacity linked to employee stock plans.\nAlongside these financing moves, the company highlighted unprecedented Phase 2 results for its VAX-31 pneumococcal vaccine, rapid progression into multiple Phase 3 trials, and completion of a large-scale manufacturing...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-is-up-55-after-unveiling-vax-31-data-phase-3-pl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-is-up-55-after-unveiling-vax-31-data-phase-3-pl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","PCVX","IE0009354923.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177933909","title":"Stock Track | Vaxcyte, Inc. Plummets 5.05% Intraday on FDA Regulatory Timing Risk Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=1177933909","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177933909?lang=en_us&edition=fundamental","pubTime":"2026-02-27 00:26","pubTimestamp":1772123183,"startTime":"0","endTime":"0","summary":"Vaxcyte, Inc. (PCVX) saw its stock price plummet by 5.05% during intraday trading on Thursday, following the disclosure of a significant regulatory risk.The company has identified a new risk in its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PCVX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":86,"code":"91000000","status":"200"}]}}